-
Intellia CEO on Crispr gene-editing treatment, secondary offering
-
Intellia shares jump on positive gene-editing data
-
Intellia has a special request from FDA for their NTLA-2002. Must know this if you hold NTLA.
-
Intellia Stock vs CRISPR Stock: The Winner Is
-
INTELLIA THERAPEUTICS INC BIG SWING | NTLA STOCK
-
Revolutionary CRISPR Therapy Tool | KEY MILESTONE Analysis on Intellia Therapeutics (NTLA) stock
-
Intellia is the leading CRISPR company
-
Revolutionary CRISPR Therapy Tool | Martin Shkreli Analyses Intellia Therapeutics (NTLA) stock
-
Intellia Therapeutics Overview
-
Intellia Therapeutics: MASSIVE Opportunity in CRISPR - $NTLA Full Analysis
-
Intellia, Regeneron complete first systemic delivery of CRISPR in body
-
CSHL Keynote, Dr. David Lebwohl, Intellia Therapeutics
-
Gene Editing Updates | CRISPR, Intellia, and Beam
-
Intellia: NTLA steady performance, well funded, no immediate catalysts - Earnings review,
-
Intellia Therapeutics, Inc NTLA Stock
관련영화
-
용호풍운 디 오리지널 City on Fire (1987)
-
서울의 봄 12.12: THE DAY (2023)
-
1947 보스톤 Boston 1947 (2020)
-
돌핀 Dolphin (2022)
-
중경삼림 리마스터링 Chungking Express (1994)
-
영웅본색 Knight Errant (1974)
-
비상선언 EMERGENCY DECLARATION (2020)
-
첨밀밀 Comrades: Almost A Love Story (1996)